Lu AF28996
20501A
Phase 1 small_molecule active
Quick answer
Lu AF28996 for Parkinson Disease is a Phase 1 program (small_molecule) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- H. Lundbeck A/S
- Indication
- Parkinson Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active